Impact of Pandemic Mitigation Efforts on Colonization and Transmission of Respiratory Pathogens and Antibiotic Resistance Genes
流行病缓解措施对呼吸道病原体和抗生素抗性基因定植和传播的影响
基本信息
- 批准号:10641008
- 负责人:
- 金额:$ 21.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-08 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAcuteAddressAdenovirusesAdultAntibiotic ResistanceAntibiotic TherapyBacteriaCOVID-19 pandemicCalendarChildClinicalDetectionDevelopmentDiseaseDwarfismEffectivenessExhibitsFaceGene ExchangesHomeHouseholdHumanInfectionInfluenzaInterruptionLicensingMeasurementMeasuresMobile Genetic ElementsModelingMonitorNasopharynxNatureOrganismPathogenesisPathogenicityPatternPeruPneumococcal ColonizationPneumoniaPrevention strategyProcessRecommendationRespiratory Signs and SymptomsRespiratory Tract InfectionsRespiratory syncytial virusRhinovirusRiskSARS-CoV-2 transmissionSamplingSocial DistanceStaphylococcus aureusStreptococcus pneumoniaeSymptomsTestingTimeVaccinationVaccinesViral Respiratory Tract InfectionVirus DiseasesVisitclinically relevantcommunity transmissionhuman coronavirusmemberpandemic impactpandemic responsepathogenprospectiveresistance generespiratoryrespiratory pathogenrespiratory virusschool closurestay-at-home ordersuccesssurveillance datatransmission processvaccine development
项目摘要
ABSTRACT
Nasopharyngeal (NP) colonization with commensal and pathogenic organisms is common and a
dynamic process. While these dynamics typically occur in the healthy state, many respiratory viruses and
colonizing bacteria are important causes of acute respiratory illness (ARI) and invasive disease. Respiratory
viruses and bacteria also exhibit interactions that are important in ARI pathogenesis. The initial period shortly
after acquisition of respiratory bacteria or infection with respiratory viruses is particularly critical, imparting an
increase in ARI risk. S. pneumoniae, S. aureus, and other colonizing bacteria also commonly express antibiotic
resistance genes that may be transferred or exchanged between co-colonizing organisms.
Broad mitigation strategies were implemented for SARS-CoV-2 pandemic control in many settings,
including use of face coverings, stay-at-home orders, and school closures. Collectively, these efforts were
associated with reduced community transmission of SARS-CoV-2. In addition, ecologic studies during these
periods also demonstrated interruptions in influenza, respiratory syncytial virus, and S. pneumoniae disease
activity that were very substantial, dwarfing the success of existing preventive strategies, including vaccines,
which are available against only few respiratory pathogens and limited in their scope and effectiveness.
Understanding the impact of mitigation strategies on the activity of colonizing respiratory pathogens beyond
SARS-CoV-2 would inform efforts to understand infection dynamics and reduce the burden of these common
yet currently unpreventable infections.
We conducted intensive household-based ARI surveillance in Lima, Peru during the same period in two
consecutive years: 2019, just prior to the COVID-19 pandemic, and 2020, during peak SARS-CoV-2 activity.
We aim to leverage this unique platform to characterize patterns of household acquisition and infection with
respiratory pathogens during periods with and without mitigation strategies through the conduct of two Specific
Aims: 1) To test the hypothesis that mitigation strategies are associated with a) fewer acquisitions of colonizing
respiratory bacteria, b) fewer infections with respiratory viruses, shorter durations of colonization/detections,
and reduced transmission of these pathogens among children and adults in households in semi-urban Peru,
and 2) To test the hypothesis that mitigation strategies are associated with fewer acquisitions, shorter duration
of detection, and reduced household transmission of nasopharyngeal antibiotic resistance genes among
children and adults in households in semi-urban Peru. A detailed understanding of the impact of these
mitigation strategies on the dynamics of colonization with clinically relevant respiratory pathogens may inform
targeted applications to reduce the global impact of ARI and pneumonia, particularly for infections that are not
yet vaccine-preventable.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CARLOS G GRIJALVA其他文献
CARLOS G GRIJALVA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CARLOS G GRIJALVA', 18)}}的其他基金
Peru Vanderbilt – PREvention through VacciNation Training (PREVENT) program
秘鲁范德比尔特 — 通过疫苗接种培训进行预防 (PREVENT) 计划
- 批准号:
10674393 - 财政年份:2023
- 资助金额:
$ 21.63万 - 项目类别:
Human rhinovirus infection and susceptibility to SARS-CoV-2 infection and symptomatic disease
人类鼻病毒感染以及对 SARS-CoV-2 感染和症状性疾病的易感性
- 批准号:
10726391 - 财政年份:2023
- 资助金额:
$ 21.63万 - 项目类别:
Impact of Pandemic Mitigation Efforts on Colonization and Transmission of Respiratory Pathogens and Antibiotic Resistance Genes
流行病缓解措施对呼吸道病原体和抗生素抗性基因定植和传播的影响
- 批准号:
10510137 - 财政年份:2022
- 资助金额:
$ 21.63万 - 项目类别:
Gestational diabetes drugs and perinatal outcomes in underserved populations
妊娠糖尿病药物和服务不足人群的围产期结局
- 批准号:
10487395 - 财政年份:2021
- 资助金额:
$ 21.63万 - 项目类别:
Gestational diabetes drugs and perinatal outcomes in underserved populations
妊娠糖尿病药物和服务不足人群的围产期结局
- 批准号:
10193041 - 财政年份:2021
- 资助金额:
$ 21.63万 - 项目类别:
Mentoring in transmission of influenza and strategies for prevention
流感传播的指导和预防策略
- 批准号:
10555283 - 财政年份:2020
- 资助金额:
$ 21.63万 - 项目类别:
Mentoring in transmission of influenza and strategies for prevention
流感传播的指导和预防策略
- 批准号:
10356800 - 财政年份:2020
- 资助金额:
$ 21.63万 - 项目类别:
Mentoring in transmission of influenza and strategies for prevention
流感传播的指导和预防策略
- 批准号:
10094190 - 财政年份:2020
- 资助金额:
$ 21.63万 - 项目类别:
Learning Health System training program: PROgRESS--Patient/ pRactice Outcomes and Research in Effectiveness and Systems Science
学习健康系统培训计划:PROgRESS--患者/实践成果以及有效性和系统科学的研究
- 批准号:
10192698 - 财政年份:2018
- 资助金额:
$ 21.63万 - 项目类别:
Learning Health System training program: PROgRESS--Patient/ pRactice Outcomes and Research in Effectiveness and Systems Science
学习健康系统培训计划:PROgRESS--患者/实践成果以及有效性和系统科学的研究
- 批准号:
10425309 - 财政年份:2018
- 资助金额:
$ 21.63万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 21.63万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 21.63万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 21.63万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 21.63万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 21.63万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 21.63万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 21.63万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 21.63万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 21.63万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 21.63万 - 项目类别:
Standard Grant














{{item.name}}会员




